Pulmonary Diseases Clinical Trials

8 recruitingLast updated: July 25, 2026

There are 8 actively recruiting pulmonary diseases clinical trials across 5 countries. Studies span Not Applicable. Top locations include Guangzhou, Guangdong, China, Beijing, Beijing Municipality, China, Brussels, Belgium. Updated daily from ClinicalTrials.gov.


Pulmonary Diseases Trials at a Glance

8 actively recruiting trials for pulmonary diseases are listed on ClinicalTrialsFinder across 6 cities in 5 countries. The largest study group is Not Applicable with 4 trials, with the heaviest enrollment activity in Guangzhou, Beijing, and Brussels. Lead sponsors running pulmonary diseases studies include Chinese Academy of Sciences, Guangdong Provincial People's Hospital, and CHU de Reims.

Browse pulmonary diseases trials by phase

Treatments under study

About Pulmonary Diseases Clinical Trials

Looking for clinical trials for Pulmonary Diseases? There are currently 2 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Pulmonary Diseases trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Pulmonary Diseases clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 18 of 8 trials

Recruiting

Exhaled Breath Analysis in Human Subjects

Exhaled Breath Pattern After Medication Intake, in OSA Patients, or Other Pulmonary Diseases
University of Zurich1,500 enrolled1 locationNCT05456009
Recruiting
Not Applicable

Effect of IMT in Patients After Acute Exacerbations of COPD

COPDChronic Obstructive Pulmonary DiseasesSymptom Exacerbation
KU Leuven358 enrolled12 locationsNCT07213128
Recruiting

Prospective Multicenter Screening for Thoracic Disease Via Radiography

Esophageal DiseasesRespiratory DiseasePulmonary Diseases
Chinese Academy of Sciences300,000 enrolled1 locationNCT07585214
Recruiting
Not Applicable

Community Exercise Treating Effect on Cardiopulmonary Disease Patients

Heart FailureCardiomyopathyCoronary Heart Disease (CHD)+5 more
Guangdong Provincial People's Hospital200 enrolled1 locationNCT07154355
Recruiting
Not Applicable

Uncuffed Endotracheal Tube vs. no Endotracheal Tube

Multiple Pulmonary Diseases
University of Minnesota200 enrolled1 locationNCT06799455
Recruiting

Assisting Pulmonary Disease Diagnosis With Ophthalmic Artificial Intelligence Technology

Artificial IntelligencePulmonary DiseasesOphthalmological Diagnostic Techniques
Zhongshan Ophthalmic Center, Sun Yat-sen University10,000 enrolled4 locationsNCT05847894
Recruiting

The Study of Differences in Eosinophil Function and Subsets in Patients With Eosinophilic Pulmonary Diseases

Eosinophil SubtypeEosinophilic Pulmonary Diseases
Peking Union Medical College Hospital300 enrolled1 locationNCT06944418
Recruiting
Not Applicable

Cohort for Research and Innovation in Chronic Inflammatory Respiratory Diseases

Chronic Inflammatory Pulmonary Diseases
CHU de Reims225 enrolled1 locationNCT02924818